We are live on ! Find out more

20 hedge funds and large institutions have $15.4M invested in Evotec in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more capital invested

Capital invested by funds: $14.5M → $15.4M (+$901K)

5% more funds holding

Funds holding: 1920 (+1)

0% more ownership

Funds ownership: 0.77%0.78% (+0%)

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

EVO Hedge Fund Activity: Q2 2023 in Review

20 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Evotec (EVO) for Q2 2023, worth a combined $15.4M — up 6.2% from $14.5M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EVO positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 3 trimmed.

The largest buyer was DCF Advisers, adding an estimated $324K. The largest seller was Jane Street, cutting an estimated $387K.

  • 20 institutional investors held Evotec (EVO) as of Q2 2023, up from 19 in Q1 2023.
  • Funds reported $15.4M of Evotec stock for Q2 2023, up 6.2% quarter-over-quarter.
  • 3 funds opened new Evotec positions in Q2 2023 and 2 closed out, a net change of +1 holder.
  • The largest Evotec buyer in Q2 2023 was DCF Advisers, an estimated $324K added.
  • The largest Evotec seller in Q2 2023 was Jane Street, an estimated $387K sold.

Based on aggregated 13F filings for Q2 2023.